Therefore, the primary aim of this study is to examine alterations in TRPV1 expression and oxidative stress levels in ADEs and peripheral blood mononuclear cells (PBMCs) from patients with schizophrenia. This evidence concerns the gene TRPV1 and schizophrenia.